CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Remote Microphonedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03897634
NCT03897634N/ACompleted

Clinical Trial of Roger Adaptive Digital Technology

Northwestern University·interventional·Posted Apr 1, 2019·Updated Jun 10, 2021

In Brief

A clinical study evaluating Remote Microphone for Hearing Loss, Sensorineural. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Despite improvements in digital hearing aid technology, many hearing aid users continue to report difficulty understanding speech in challenging listening environments. Remote microphones have been shown to provide benefit in the most common of these challenging listening environments: distant speakers, background noise, and reverberation. Despite demonstrated benefit, there is a low rate of remote microphone use among adult hearing aid users. One reason for low uptake may be an uncertainty among hearing healthcare providers and potential users regarding expected clinically relevant benefit. This clinical trial will attempt the following: 1. To describe the range of remote microphone benefit among adults with mild-to-moderate sensorineural hearing loss 2. To determine specific individual factors beyond the audiogram that are associated with greater benefit from remote microphones

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 1, 2019
Enrollment StartAug 30, 2019
Primary CompletionMar 15, 2020
Study CompletionApr 15, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.3 years ago

Interventions

Remote Microphonedevice

Experienced hearing aid users will be trained on and use a remote microphone for 30 days. Pre- and Post- measures will be taken to determine benefit. Participant characteristics will also be assessed (such as self-efficacy) to explore personality factors that may contribute to benefit from devices.